BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10524276)

  • 1. Utilization of D-amino acids by Fusobacterium nucleatum and Fusobacterium varium.
    Ramezani M; MacIntosh SE; White RL
    Amino Acids; 1999; 17(2):185-93. PubMed ID: 10524276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic investigation of amino acid catabolism in the indigenous gut anaerobe Fusobacterium varium.
    Potrykus J; White RL; Bearne SL
    Proteomics; 2008 Jul; 8(13):2691-703. PubMed ID: 18546150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the amino acid uptake profile of reference and clinical isolates of Fusobacterium nucleatum subspecies.
    Gharbia SE; Shah HN
    Oral Microbiol Immunol; 1991 Oct; 6(5):264-9. PubMed ID: 1820562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid utilization by Fusobacterium nucleatum grown in a chemically defined medium.
    Dzink JL; Socransky SS
    Oral Microbiol Immunol; 1990 Jun; 5(3):172-4. PubMed ID: 2080074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of amino acids and peptides by Fusobacterium nucleatum.
    Bakken V; Högh BT; Jensen HB
    Scand J Dent Res; 1989 Feb; 97(1):43-53. PubMed ID: 2565597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic footprinting of the anaerobic bacterium Fusobacterium varium using 1H NMR spectroscopy.
    Resmer KL; White RL
    Mol Biosyst; 2011 Jul; 7(7):2220-7. PubMed ID: 21547305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid fermentation by Fusobacterium nucleatum.
    Loesche WJ; Gibbons RJ
    Arch Oral Biol; 1968 Feb; 13(2):191-202. PubMed ID: 5238887
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathways of glutamate catabolism among Fusobacterium species.
    Gharbia SE; Shah HN
    J Gen Microbiol; 1991 May; 137(5):1201-6. PubMed ID: 1678005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in growth and polyglucose synthesis in response to fructose metabolism by Fusobacterium nucleatum grown in continuous culture.
    Zilm PS; Gully NJ; Rogers AH
    Oral Microbiol Immunol; 2003 Aug; 18(4):260-2. PubMed ID: 12823803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate racemization and catabolism in Fusobacterium varium.
    Ramezani M; Resmer KL; White RL
    FEBS J; 2011 Jul; 278(14):2540-51. PubMed ID: 21575137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of the growth and metabolism of Fusobacterium nucleatum ATCC 10953 in continuous culture.
    Rogers AH; Zilm PS; Gully NJ; Pfennig AL; Marsh PD
    Oral Microbiol Immunol; 1991 Aug; 6(4):250-5. PubMed ID: 1812468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of electrical bioimpedance for studying utilization of amino acids and peptides by Porphyromonas gingivalis, Fusobacterium nucleatum, and Treponema denticola.
    Shah HN; Gharbia SE; Zhang MI
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S404-7. PubMed ID: 8391864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic investigation of glucose metabolism in the butyrate-producing gut anaerobe Fusobacterium varium.
    Potrykus J; Mahaney B; White RL; Bearne SL
    Proteomics; 2007 Jun; 7(11):1839-53. PubMed ID: 17464938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The breakdown and utilization of peptides by strains of Fusobacterium nucleatum.
    Rogers AH; Gully NJ; Pfennig AL; Zilm PS
    Oral Microbiol Immunol; 1992 Oct; 7(5):299-303. PubMed ID: 1494454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth pH and transient increases in amino acid availability influence polyglucose synthesis by Fusobacterium nucleatum grown in continuous culture.
    Zilm PS; Gully NJ; Rogers AH
    FEMS Microbiol Lett; 2002 Oct; 215(2):203-8. PubMed ID: 12399036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid-dependent transport of sugars by Fusobacterium nucleatum ATCC 10953.
    Robrish SA; Oliver C; Thompson J
    J Bacteriol; 1987 Sep; 169(9):3891-7. PubMed ID: 3114229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia.
    Sheng J; Nguyen PT; Baldeck JD; Olsson J; Marquis RE
    Arch Oral Biol; 2006 Nov; 51(11):1015-23. PubMed ID: 16806047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptide utilization by the periodontal pathogens Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum.
    Takahashi N; Sato T
    Oral Microbiol Immunol; 2002 Feb; 17(1):50-4. PubMed ID: 11860556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium.
    Karpathy SE; Qin X; Gioia J; Jiang H; Liu Y; Petrosino JF; Yerrapragada S; Fox GE; Haake SK; Weinstock GM; Highlander SK
    PLoS One; 2007 Aug; 2(7):e659. PubMed ID: 17668047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and enzymic analysis of a novel protein associated with production of hydrogen sulfide and L-serine from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.
    Yoshida Y; Suwabe K; Nagano K; Kezuka Y; Kato H; Yoshimura F
    Microbiology (Reading); 2011 Jul; 157(Pt 7):2164-2171. PubMed ID: 21493682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.